{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:10:47Z","timestamp":1773303047476,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Industrial Research Fund of the KU Leuven"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.yebeh.2015.03.019","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T03:31:07Z","timestamp":1428031867000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish"],"prefix":"10.1016","volume":"45","author":[{"given":"Karine","family":"Leclercq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Afrikanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"De Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia E.","family":"Buenafe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara C.","family":"Rospo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Van Eeckhaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.M.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander D.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Smolders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila V.","family":"Esguerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1632-4101","authenticated-orcid":false,"given":"Rafal M.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2015.03.019_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-1211(02)00073-6","article-title":"Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy","volume":"50","author":"L\u00f6scher","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","article-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","volume":"129","author":"Remy","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0025","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1528-1167.2012.03541.x","article-title":"Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design","volume":"53","author":"Simonato","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1528-1167.2011.03391.x","article-title":"NIH public access","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2174\/0929867320666131119152613","article-title":"Models in research of pharmacoresistant epilepsy: present and future in development of antiepileptic drugs","volume":"21","author":"Kov\u00e1cs","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0045","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(98)00087-4","article-title":"Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of genetic factors","volume":"33","author":"Ebert","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.eplepsyres.2012.10.003","article-title":"Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats","volume":"104","author":"Srivastava","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbr.2010.06.001","article-title":"Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research","volume":"214","author":"Champagne","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0065","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","article-title":"Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression","volume":"131","author":"Baraban","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1528-1167.2007.01075.x","article-title":"A large-scale mutagenesis screen to identify seizure-resistant zebrafish","volume":"48","author":"Baraban","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0075","doi-asserted-by":"crossref","first-page":"e54166","DOI":"10.1371\/journal.pone.0054166","article-title":"Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs","volume":"8","author":"Afrikanova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1242\/dmm.002139","article-title":"Zebrafish as a model for studying genetic aspects of epilepsy","volume":"3","author":"Hortopan","year":"2010","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0085","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/hmg\/ddr608","article-title":"Impaired neural development in a zebrafish model for Lowe syndrome","volume":"21","author":"Ramirez","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/dneu.20937","article-title":"Expression and function of KCNQ channels in larval zebrafish","volume":"72","author":"Chege","year":"2012","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1242\/dmm.009480","article-title":"Generation and validation of a zebrafish model of EAST (epilepsy, ataxia, sensorineural deafness and tubulopathy) syndrome","volume":"6","author":"Mahmood","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0100","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/ncomms3410","article-title":"Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment","volume":"4","author":"Baraban","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ajhg.2013.09.017","article-title":"De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome","volume":"93","author":"Suls","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1242\/dmm.010090","article-title":"Identification of compounds with novel anti-convulsant properties in a zebrafish model of epileptic seizures","volume":"5","author":"Baxendale","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0115","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","article-title":"Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice","volume":"16","author":"Mandhane","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0404.2011.01596.x","article-title":"Mechanism of action of vigabatrin: correcting misperceptions","volume":"124","author":"Ben-Menachem","year":"2011","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)02149-6","article-title":"Glutamate metabotropic receptors as targets for drug therapy in epilepsy","volume":"476","author":"Moldrich","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0135","series-title":"Jasper's basic mechanisms of the epilepsies","first-page":"122","article-title":"Glutamatergic mechanisms related to epilepsy: ionotropic receptors","author":"Dingledine","year":"2012"},{"issue":"Suppl. 8","key":"10.1016\/j.yebeh.2015.03.019_bb0140","first-page":"14","article-title":"The role of glutamate in epilepsy and other CNS disorders","volume":"44","author":"Meldrum","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eplepsyres.2007.10.007","article-title":"Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin","volume":"78","author":"Meurs","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0155","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1523\/JNEUROSCI.23-18-07069.2003","article-title":"Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons","volume":"23","author":"Gryder","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ane.12099","article-title":"AMPA receptors as a molecular target in epilepsy therapy","volume":"127","author":"Rogawski","year":"2013","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0079-6123(08)60448-3","article-title":"Involvement of glutamate in human epileptic activities","volume":"116","author":"Scheyer","year":"1998","journal-title":"Prog Brain Res"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2015.03.019_bb0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1535-7597.2004.46011.x","article-title":"Another \u201ctonic\u201d in the realm of epilepsy","volume":"4","author":"Mody","year":"2004","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0180","first-page":"1033","article-title":"Alterations of GABA-mediated synaptic transmission in human epilepsy","volume":"44","author":"Lloyd","year":"1986","journal-title":"Adv Neurol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0185","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0006-2952(78)90103-X","article-title":"The role of 2-keto-4-pentenoic acid in seizures induced by allylglycine","volume":"27","author":"Horton","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.1977.tb10710.x","article-title":"Brain and blood levels of allylglycine in mice following doses sufficient to inhibit glutamate decarboxylase","volume":"29","author":"Taberner","year":"1977","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01252610","article-title":"Regional changes in transmitter amino acids during focal and generalized seizures in rats","volume":"63","author":"Chapman","year":"1985","journal-title":"J Neural Transm"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0200","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/0006-2952(76)90193-3","article-title":"The effect of the convulsant allylglycine (2-amino-4-pentenoic acid) on the activity of glutamic acid decarboxylase and the concentration of GABA in different regions of guinea pig brain","volume":"25","author":"Fisher","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1476-5381.1973.tb08267.x","article-title":"Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase","volume":"49","author":"Horton","year":"1973","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/226373a0","article-title":"Inhibition of Mauthner cells by allylglycine","volume":"226","author":"Roper","year":"1970","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2015.03.019_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2125.1979.tb04666.x","article-title":"Clobazam: anticonvulsant action in animal models of epilepsy [proceedings]","volume":"7","author":"Meldrum","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0220","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2739\/kurumemedj.37.253","article-title":"Effects of anticonvulsants on the electroconvulsive threshold lowered by DA, 5-HT or GABA depletion","volume":"37","author":"Nakamura","year":"1989","journal-title":"Kurume Med J"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0091-3057(79)90017-0","article-title":"Effects of some anti-epileptic, neuroleptic and gabaminergic drugs on convulsions induced by d,l-allylglycine","volume":"11","author":"Ashton","year":"1979","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0230","first-page":"529","article-title":"Effects of flunarizine on experimentally-induced convulsions in animals","volume":"1","author":"Drago","year":"1986","journal-title":"Funct Neurol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/dneu.20813","article-title":"The promise of an interneuron\u2010based cell therapy for epilepsy","volume":"71","author":"Sebe","year":"2011","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fncel.2013.00167","article-title":"Differential vulnerability of interneurons in the epileptic hippocampus","volume":"7","author":"Marx","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1009","article-title":"Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans","volume":"32","author":"Kitamura","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0250","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/08830738050200042001","article-title":"X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, \u201cinterneuronopathy\u201d","volume":"20","author":"Kato","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0255","first-page":"4","article-title":"Mutations in ARX result in several defects involving GABAergic neurons","volume":"4","author":"Friocourt","year":"2010","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0260","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1152\/jn.00056.2011","article-title":"Deletion of Dlx1 results in reduced glutamatergic input to hippocampal interneurons","volume":"105","author":"Jones","year":"2011","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0265","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1523\/JNEUROSCI.23-02-00622.2003","article-title":"Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction","volume":"23","author":"Powell","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0270","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cne.20647","article-title":"Region- and age-specific deficits in gamma-aminobutyric acidergic neuron development in the telencephalon of the uPAR(\u2212\/\u2212) mouse","volume":"489","author":"Eagleson","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.mcn.2007.02.017","article-title":"Postnatal alterations of the inhibitory synaptic responses recorded from cortical pyramidal neurons in the Lis1\/sLis1 mutant mouse","volume":"35","author":"Vald\u00e9s-S\u00e1nchez","year":"2007","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0280","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1152\/jn.00938.2007","article-title":"Characterization of inhibitory circuits in the malformed hippocampus of Lis1 mutant mice","volume":"98","author":"Jones","year":"2007","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0285","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ncomms1736","article-title":"LIS1-dependent retrograde translocation of excitatory synapses in developing interneuron dendrites","volume":"3","author":"Kawabata","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0290","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1152\/jn.00392.2009","article-title":"Inhibitory inputs to hippocampal interneurons are reorganized in Lis1 mutant mice","volume":"102","author":"Jones","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0295","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0305","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-8993(00)02888-2","article-title":"Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background","volume":"884","author":"Schauwecker","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0310","doi-asserted-by":"crossref","first-page":"13718","DOI":"10.1523\/JNEUROSCI.1887-10.2010","article-title":"Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish","volume":"30","author":"Hortopan","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneumeth.2004.10.013","article-title":"Determination of amino acids associated with cerebral ischaemia in rat brain microdialysates using narrowbore liquid chromatography and fluorescence detection","volume":"144","author":"Van Hemelrijck","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0320","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-2952(69)90018-5","article-title":"Glutamic acid decarboxylase inhibition and ultrastructural changes by the convulsant drug allylglycine","volume":"18","author":"Alberici","year":"1969","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0325","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1528-1167.2009.02086.x","article-title":"Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation","volume":"50","author":"Barnwell","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0330","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0306-4522(00)00400-0","article-title":"Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels","volume":"101","author":"Pena","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2005.01.006","article-title":"Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs","volume":"64","author":"Tutka","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/epi.12296","article-title":"Issues related to developments of new antiseizure treatments","volume":"54","author":"Wilcox","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0345","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/cn400140e","article-title":"Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models","volume":"4","author":"Buenafe","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0350","first-page":"477P","article-title":"A comparison of the effects of allylglycine and 2-keto-4-pentenoic acid on cerebral glutamic acid decarboxylase activity and convulsions in mice","volume":"3","author":"Horton","year":"1977","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0355","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0361-9230(80)90131-8","article-title":"GABA metabolism in O2-induced convulsions","volume":"5","author":"Faiman","year":"1980","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(98)00563-0","article-title":"Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid","volume":"802","author":"Lima","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0365","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1096-9861(19990927)412:3<488::AID-CNE8>3.0.CO;2-6","article-title":"Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy","volume":"412","author":"Esclapez","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0370","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s100720200055","article-title":"Glutamic acid decarboxylase autoantibodies and neurological disorders","volume":"23","author":"Vianello","year":"2002","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0375","first-page":"64","article-title":"Role of GABA in the genesis of chemoconvulsant seizures","author":"Gale","year":"1992","journal-title":"Toxicol Lett"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2015.03.019_bb0380","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1528-1167.2010.02622.x","article-title":"Glutamate and GABA in the balance: convergent pathways sustain seizures during status epilepticus","volume":"51","author":"Naylor","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0385","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1254\/jphs.09225FP","article-title":"Effects of antiepileptics on behavioral and electroencephalographic seizure induced by pentetrazol in mice","volume":"112","author":"Watanabe","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0390","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pediatrneurol.2007.09.008","article-title":"Choosing the correct AED: from animal studies to the clinic","volume":"38","author":"Holmes","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0395","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuropharm.2008.05.002","article-title":"Imidazenil: a low efficacy agonist at alpha1 \u2014 but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem","volume":"55","author":"Auta","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0400","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0022-3565(25)12467-1","article-title":"Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio","volume":"253","author":"Turski","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0405","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0269881107082900","article-title":"Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0410","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.physbeh.2012.04.016","article-title":"Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network","volume":"107","author":"Johnson","year":"2012","journal-title":"Physiol Behav"},{"key":"10.1016\/j.yebeh.2015.03.019_bb0415","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1476-5381.1985.tb09461.x","article-title":"Modulation of 5-hydroxytryptamine-induced head-twitch response by drugs acting at GABA and related receptors","volume":"86","author":"Handley","year":"1985","journal-title":"Br J Pharmacol"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T21:16:46Z","timestamp":1747862206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505015001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":83,"alternative-id":["S1525505015001249"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.03.019","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}